In terms of sequence of RT and IT, administration of CTLA‐4 inhibitors can induce anti‐tumor immunity both before and after SBRT,4 however PD‐1/PD‐L1 inhibitors are ideally administrated during SBRT and need to continue for some days.38 The gene discussed is CTLA4; the disease is neoplasm.